+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

US Molecular Blood Typing, Grouping and Infectious Disease NAT Market to 2024: Supplier Shares and Strategies - Blood Banks, Hospitals, Commercial Labs - Emerging Technologies, Latest Instrumentation, Competitive Analysis

  • PDF Icon

    Report

  • 460 Pages
  • September 2020
  • Region: United States
  • VPG Market Research
  • ID: 4911994
This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future marketing and technological trends in US; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Companies Profiled

  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Diagast
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic
  • Immucor
  • LabCorp
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Quest Diagnostics
  • Quidel
  • Roche
  • Siemens Healthineers
  • Tecan
  • Thermo Fisher